 |
|
|
L. Fredrik Jarskog, M.D.
Associate Professor of Clinical Psychiatry
Chief of Clinical Therapeutics, Lieber Center for Schizophrenia Research and Treatment,
New York State Psychiatric Institute
Research Psychiatrist, Division of Molecular Imaging & Neuropathology,
New York State Psychiatric Institute
|
|
|
|
|
|
|
|
|
|
 |
Undergraduate: Johns Hopkins University, B.A., 1982-1986
Medical School: Wake Forest University School of Medicine, M.D., 1987-1991
Internship: Wake Forest University School of Medicine, 1991-1992
Residency: University of North Carolina School of Medicine, 1992-1996
Fellowship: University of North Carolina School of Medicine, 1996-1997
Board Certifications: American Board of Psychiatry and Neurology
|
 |
• Schizophrenia, psychopharmacology
• Schizophrenia, neuropathology
|
 |
Address:
NYS Psychiatric Institute
Room 5807 Unit/Box:42
1051 Riverside Drive
New York, NY 10032
Phone: 212-543-6711
Fax: 212-543-1350
lj2211@columbia.edu
|
 |
1. Cox ET, Brennaman LH, Gable KL, Hamer RM, LaMantia A-S, Lieberman JA, Gilmore JH, Maness PF, Jarskog LF: Developmental regulation of neural cell adhesion molecule (NCAM) in human prefrontal cortex.. Neuroscience 2009;In press
2. Salimi K, Jarskog LF, Lieberman JA: Antipsychotic drugs for first-episode psychosis: a comparative review.. CNS Drugs 2009;In press
3. Henson MA, Roberts AC, Salimi K, Vadlamudi S, Hamer RM, Gilmore JH, Jarskog LF, Philpot BD: Developmental regulation of the NMDA receptor subunits, NR1 and NR3A, in human prefrontal cortex.. Cerebral Cortex 2008;18: 2560-2573
4. Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF: Synaptophysin and PSD-95 in the human prefrontal cortex from mid-gestation into early adulthood. Neuroscience 2007;149: 582-591
5. Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, Tong RI, Lieberman JA: Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology 2007;32: 95-102
|
 |
|
FACULTY ONLY
|
|
|
